Search
Search Results
##search.searchResults.foundPlural##
-
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1957PDF: 711HTML: 683Table1: patient's characteristics: 155Table 2: profile of each patient: 178 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2414PDF: 860HTML: 2457 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4100PDF: 1586HTML: 949 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
956PDF: 582HTML: 339 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
8003PDF: 3240HTML: 1225 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1961PDF: 811HTML: 221 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2018PDF: 796HTML: 1036 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
939PDF: 573HTML: 2193Cover Letter: 190 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3251PDF: 934HTML: 2953 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
817PDF: 539HTML: 4016 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3935PDF: 1492HTML: 9188Untitled: 277Untitled: 183Untitled: 168Untitled: 164Untitled: 180Untitled: 338 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2627PDF: 942HTML: 3604 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2487PDF: 922HTML: 528 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7837PDF: 718HTML: 213 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2493PDF: 838HTML: 8820Efremov 1: 226Efremov 2: 189 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1830HTML: 1445PDF: 1081 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4753PDF: 2834HTML: 2281 -
-
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1571PDF: 1204HTML: 189 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2449HTML: 271PDF: 868 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1315PDF: 966HTML: 287Suppl. Figure: 182Suppl. Tables: 204 -
WHAT ARE FUNGAL INFECTIONS?
4177PDF: 2374HTML: 27593de Pauw: 235 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
651PDF: 510HTML: 86 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1525PDF: 941HTML: 222 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1808PDF: 809HTML: 10234Figures 1,2,3: 173 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
998PDF: 537HTML: 7810 -
-
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1390PDF: 679HTML: 1378cover letter: 204 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1243PDF: 473HTML: 18570Figure 1: 168Figure 2: 150Figure 3: 167Figure 4: 205Figure 5: 176







